Literature DB >> 21634238

T-cell immunity in human chronic toxoplasmosis.

Ibrahim M El-Kady1.   

Abstract

Toxoplasmosis is a disease affecting 500 million people worldwide. The seroprevalence varies (from 5% to 90%), depending on geographical location, age, habit of eating raw meat or unwashed fruit and vegetables, and general level of hygiene. The incidence of infections is higher in warmer and humid climate and increases with age. The disease can be congenital or acquired. Cell response (TNF-alpha and IFN-gamma secreted by Th1 cells) and humoral response (IL-4, and IL-10 secreted by Th2 cells) were evaluated. This study assessed the effect of T. gondii on chosen indices of the immune response. The study involved 45 women infected with T. gondii (aged 18-42 years) proven have a chronic toxoplasmosis (IgG positive & IgM negative). The control group consisted of 25 healthy women (aged 18-45 years) (IgG and IgM negative). The results showed that patients infected with T. gondii had increased production of theTh-1 cytokines involved TNF-alpha and IFN-gamma that responsible for the cellular response compared to controls. Also, increased production of Th2 cytokines involved IL-4 and IL-10 that responsible for humoral response compared to controls.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21634238

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  8 in total

1.  In-depth computational analysis of calcium-dependent protein kinase 3 of Toxoplasma gondii provides promising targets for vaccination.

Authors:  Hamidreza Majidiani; Shahrzad Soltani; Ali Dalir Ghaffari; Mohamad Sabaghan; Ali Taghipour; Masoud Foroutan
Journal:  Clin Exp Vaccine Res       Date:  2020-07-31

2.  Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis.

Authors:  Guanghui Zhao; Aihua Zhou; Gang Lv; Min Meng; Min Sun; Yang Bai; Yali Han; Lin Wang; Huaiyu Zhou; Hua Cong; Qunli Zhao; Xing-Quan Zhu; Shenyi He
Journal:  BMC Infect Dis       Date:  2013-05-07       Impact factor: 3.090

3.  Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii.

Authors:  Jian Zhou; Lin Wang; Gang Lu; Aihua Zhou; Meiyan Zhu; Qihang Li; Zhilin Wang; Miradel Arken; Ao Wang; Shenyi He
Journal:  Parasite       Date:  2016-04-07       Impact factor: 3.000

4.  Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice.

Authors:  Yali Han; Aihua Zhou; Gang Lu; Guanghui Zhao; Lin Wang; Jingjing Guo; Pengxia Song; Jian Zhou; Huaiyu Zhou; Hua Cong; Shenyi He
Journal:  BMC Infect Dis       Date:  2017-01-11       Impact factor: 3.090

5.  Bioinformatics analysis of calcium-dependent protein kinase 4 (CDPK4) as Toxoplasma gondii vaccine target.

Authors:  Masoud Foroutan; Shahrzad Soltani; Ali Taghipour; Ali Dalir Ghaffari; Hamidreza Majidiani; Mohamad Sabaghan
Journal:  BMC Res Notes       Date:  2021-02-06

6.  Immunoinformatic Analysis of Calcium-Dependent Protein Kinase 7 (CDPK7) Showed Potential Targets for Toxoplasma gondii Vaccine.

Authors:  Ali Taghipour; Sanaz Tavakoli; Mohamad Sabaghan; Masoud Foroutan; Hamidreza Majidiani; Shahrzad Soltani; Milad Badri; Ali Dalir Ghaffari; Sheyda Soltani
Journal:  J Parasitol Res       Date:  2021-07-08

7.  DNA Vaccines Encoding Toxoplasma gondii Cathepsin C 1 Induce Protection against Toxoplasmosis in Mice.

Authors:  Yali Han; Aihua Zhou; Gang Lu; Guanghui Zhao; Wenchao Sha; Lin Wang; Jingjing Guo; Jian Zhou; Huaiyu Zhou; Hua Cong; Shenyi He
Journal:  Korean J Parasitol       Date:  2017-10-31       Impact factor: 1.341

8.  Immunoinformatic analysis of immunogenic B- and T-cell epitopes of MIC4 protein to designing a vaccine candidate against Toxoplasma gondii through an in-silico approach.

Authors:  Ali Dalir Ghaffari; Abdolhossein Dalimi; Fatemeh Ghaffarifar; Majid Pirestani; Hamidreza Majidiani
Journal:  Clin Exp Vaccine Res       Date:  2021-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.